Author: OurCrowd

[Polarisqb in NewsDirect] POLARISqb and Syntekabio sign MOU for Collaborative AI and Quantum-powered Drug Development Service

POLARISqb, the first company in the world to develop a drug discovery engine that utilizes the optimization power of quantum computing, announced that it has signed an MOU with Syntekabio (KOSDAQ: 226330), an Artificial Intelligence (AI) based drug development company. The partnership, which will combine the companies’ vanguard drug research platforms, will provide a collaborative drug development service as well as develop new molecular leads. Read more...

Read More